Breast cancer patients who exercise pre-diagnosis are at lower risk for heart disease

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Older patients with breast cancer who exercised before diagnosis may be at a lower risk for cardiovascular disease compared to those who did not, according to a study in JACC: CardioOncology.

Researchers examined 4,015 patients with a confirmed diagnosis of primary breast cancer enrolled in the Women’s Health Initiative, which included postmenopausal women age 50-79. Women with cardiovascular disease, a history of any other malignancy prior to enrollment or a body mass index less than or equal to 18.5kg/m2 were excluded.

In the WHI, exercise history at baseline and follow-up were assessed with a questionnaire where patients reported the frequency, duration and intensity of leisure-time physical activity. Researchers examined exercise data that were collected at the visit closest to breast cancer diagnosis and that was between five years and one month prior to diagnosis.

Metabolic equivalent task values were assigned for levels of physical activity per week and exercise was categorized in quartiles: less than 2.5 MET-hours/week (994 patients); 2.50 to greater than 8.625 (1,008 patients); 8.625 to less than 18 (1,011 patients); and greater than or equal to 18 (1,002 patients).

During the study, 324 cardiovascular events occurred. Researchers found that exercising prior to a breast cancer diagnosis was associated with a 20-37% reduction in the risk of first cardiovascular events. The risk of heart attack and heart failure were not impacted, suggesting that exercise may be associated with a greater risk reduction in other cardiovascular events such as angina, coronary revascularization, peripheral artery disease or stroke. Individuals who met current physical activity recommendations (9 MET-hours/week), prior to diagnosis had a 46% lower risk of coronary heart disease death compared to those who exercised less than recommended.

“This study is the first to show the exposure to exercise prior to a cancer diagnosis may potentially protect against or mitigate the established adverse cardiovascular consequences observed in breast cancer patients,” lead author Tochi M. Okwuosa, director of the cardio-oncology program at Rush University Medical Center, said in a statement.

Table of Contents

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login